A 2018 review of sixteen reports of cannabis-centered medicines for neuropathic discomfort, almost all of which analyzed a cannabinoid preparation named nabiximols (model identify Sativex; a mouth spray made up of equally THC and CBD that may be authorised in certain nations but not in the United States), discovered lower- to moderate-excellent pro